- Home
- TSHA vs TFIN Comparison
TSHA vs TFIN Comparison
Compare TSHA & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSHA | TFIN |
|---|---|---|
| Founded | 2019 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TSHA | TFIN |
|---|---|---|
| Price | $5.48 | $63.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $10.22 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 3.8M | 234.6K |
| Earning Date | 11-04-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | $6,310,000.00 | ★ $412,291,000.00 |
| Revenue This Year | N/A | $10.27 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | ★ N/A | $228.52 |
| Revenue Growth | N/A | ★ 3.78 |
| 52 Week Low | $1.05 | $42.90 |
| 52 Week High | $5.95 | $99.18 |
Technical Indicators
Market Signals| Indicator | TSHA | TFIN |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 64.98 |
| Support Level | $5.22 | $60.87 |
| Resistance Level | $5.95 | $63.55 |
| Average True Range (ATR) | 0.34 | 2.74 |
| MACD | 0.05 | 0.46 |
| Stochastic Oscillator | 75.26 | 78.50 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.